NCT06377930Phase 2Completed

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Study sponsor: Rapport Therapeutics Inc. · RAPP

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2025-09-26Actual

Enrollment · participants30Actual

Source updated2026-02-05Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-02-05 · 3 fields changed

Completion date type changed

− Before

~~Estimated~~

+ After

Actual

Primary completion date changed

− Before

~~28 Jul 2025~~

+ After

26 Sep 2025

Recruitment status changed

− Before

~~Active not recruiting~~

+ After

Completed

Check registry source